Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
基本信息
- 批准号:10413022
- 负责人:
- 金额:$ 103.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-08 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdherenceAlgorithmsAsian AmericansAsian populationAutomobile DrivingBehaviorBiologicalBiologyBody SizeBreast Cancer PatientCaliforniaCancer BiologyCancer PrognosisCellsCharacteristicsChineseClinicalCohort StudiesComplementary and alternative medicineDataDietary intakeElectronic Health RecordEpidemiologyEthnic OriginEthnic groupGeneticHealth PromotionHealth behaviorHealthcare SystemsHeterogeneityImmigrationImmuneImmune responseImmunobiologyImmunogenomicsImmunologic ReceptorsIndividualJapaneseKnowledgeLife StyleMaintenanceMalignant NeoplasmsMammary NeoplasmsModelingNeighborhoodsOutcomePathway interactionsPatient Self-ReportPatientsPatternPhenotypePlantsPopulationPopulation GroupPopulation HeterogeneityPrevalencePrognostic FactorRaceResearchResourcesSamplingSiteSocial EnvironmentSocial supportSocioeconomic StatusSurvival RateThe Cancer Genome AtlasTimeTissue SampleTissuesTranslatingTreatment FactorTreatment outcomeTumor TissueTumor-infiltrating immune cellsUnited StatesWomanWomen&aposs Groupanti-tumor immune responsebaseblack womenbreast cancer diagnosisbreast cancer family registrybreast cancer survivalcancer health disparitycancer immunobiologycancer immunotherapycancer survivalchemotherapycohortcomparison groupcontextual factorsdata registrydisorder riskethnic differenceexperiencefollow-uphealth care availabilityhormone therapyimprovedinsightlifestyle factorsmalignant breast neoplasmmortalitymulti-ethnicneoplasm registryprognosticprognostic assaysprognostic indicatorprotective factorsracial and ethnicracial and ethnic disparitiessocial culturetissue archivetranscriptome sequencingtreatment adherencetumortumor microenvironment
项目摘要
Abstract
Asian American women experience more favorable cancer survival than other US racial/ethnic groups, even
after accounting for known prognostic indicators. Breast cancer, which follows this pattern, is a useful model for
understanding factors contributing to this intriguing survival advantage, given that it is the most common
cancer in Asian American women, and has established clinical, biological/genetic, and lifestyle prognostic
factors. Thus, studying the breast cancer survival advantage in Asian American women has the potential to
identify protective factors that may benefit all patients. We propose to investigate multilevel factors (health
behaviors and contextual factors, clinical characteristics, treatment, and tumor immune response) in relation to
overall and breast cancer-specific mortality in Asian American breast cancer cases. However, the Asian
American population is heterogeneous, with lifestyle factors and disease risks (e.g., breast cancer survival
rates) varying by specific ethnicity and by immigration status. Many studies have shown the importance of
population disaggregation to uncovering meaningful differences among Asian American ethnic groups, but no
single study to date includes adequate Asian American ethnic group population samples. To overcome this
limitation, we will conduct the proposed research in integrated data and biospecimens from four established
cohort studies enriched with Asian American breast cancer cases. These studies together include 4,219 Asian
American patients (1,848 Chinese, 602 Japanese, 1,538 Filipinas) and 5,386 non-Latina White women with
breast cancer as a comparison group. In Specific Aim 1, we will assess contributions of individual-level lifestyle
and health behaviors and multilevel neighborhood social context and sociocultural factors to survival
differences among the Asian American ethnic groups relative to non-Latina Whites. In Specific Aim 2, we will
evaluate how specific treatment factors impact survival for 4,373 Asian Americans compared to 4,373 non-
Latina Whites, taking advantage of electronic health record data from an equal-access healthcare system. In
Specific Aim 3, we will characterize the immune infiltrates in the breast tumor microenvironment from 1,200
Asian American (from Aim 1) and 714 non-Latina White (from TCGA) patients using immunogenomic profiling,
and to determine the associations of immune phenotypes with patient survival among Asian Americans and
with exposure factors from Aim 1. Thus, using existing resources, this study will comprehensively assess
factors including health behaviors and neighborhood context, lifestyle, treatment, tumor immuno-biology, and
their contributions to the survival advantage in Asian American women. The proposed study makes efficient
use of data from numerous breast cancer studies to gain insight for strategies that may advance knowledge
about the management of breast cancer for all women.
抽象的
亚裔美国女性比其他美国种族/族裔群体的癌症生存率更高,甚至
在考虑了已知的预后指标后。遵循这种模式的乳腺癌是一个有用的模型
了解促成这种有趣的生存优势的因素,因为它是最常见的
亚裔美国女性的癌症,并已建立临床、生物/遗传和生活方式预后
因素。因此,研究亚裔美国女性的乳腺癌生存优势有可能
确定可能使所有患者受益的保护因素。我们建议调查多层次因素(健康
行为和背景因素、临床特征、治疗和肿瘤免疫反应)
亚裔美国乳腺癌病例的总体死亡率和乳腺癌特异性死亡率。然而,亚洲
美国人口具有异质性,受生活方式因素和疾病风险(例如乳腺癌生存率)的影响
率)因特定种族和移民身份而异。许多研究表明了重要性
人口分类以揭示亚裔美国族群之间有意义的差异,但没有
迄今为止的一项研究包括足够的亚裔美国人群体人口样本。为了克服这个
限制,我们将在四个已建立的综合数据和生物样本中进行拟议的研究
队列研究丰富了亚裔美国人乳腺癌病例。这些研究总共包括 4,219 名亚洲人
美国患者(1,848 名中国人、602 名日本人、1,538 名菲律宾人)和 5,386 名非拉丁裔白人女性患有
乳腺癌作为对照组。在具体目标 1 中,我们将评估个人生活方式的贡献
健康行为以及多层次邻里社会背景和社会文化因素对生存的影响
亚裔美国人与非拉丁裔白人之间的差异。在具体目标 2 中,我们将
评估特定治疗因素如何影响 4,373 名亚裔美国人与 4,373 名非亚裔美国人的生存率
拉丁裔白人利用平等医疗保健系统的电子健康记录数据。在
具体目标 3,我们将表征 1,200 个乳腺肿瘤微环境中的免疫浸润
使用免疫基因组分析对亚裔美国人(来自目标 1)和 714 名非拉丁白人(来自 TCGA)患者进行分析,
并确定亚裔美国人和亚裔患者免疫表型与患者生存率的关系
与目标 1 中的暴露因素。因此,利用现有资源,本研究将全面评估
因素包括健康行为和邻里环境、生活方式、治疗、肿瘤免疫生物学以及
她们对亚裔美国女性生存优势的贡献。拟议的研究使有效
使用大量乳腺癌研究的数据来深入了解可能推进知识的策略
关于所有女性乳腺癌的管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scarlett L Gomez其他文献
Scarlett L Gomez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scarlett L Gomez', 18)}}的其他基金
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
9973785 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
10643861 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
10186715 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
10176166 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
9802764 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
10410413 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
10651763 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men
项目 1:非裔美国男性的多层次社会压力源和侵袭性前列腺癌
- 批准号:
10249993 - 财政年份:2018
- 资助金额:
$ 103.15万 - 项目类别:
Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men
项目 1:非裔美国男性的多层次社会压力源和侵袭性前列腺癌
- 批准号:
9982835 - 财政年份:2018
- 资助金额:
$ 103.15万 - 项目类别:
Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men
项目 1:非裔美国男性的多层次社会压力源和侵袭性前列腺癌
- 批准号:
10447153 - 财政年份:2018
- 资助金额:
$ 103.15万 - 项目类别:
相似国自然基金
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CAS理论视角下农村老年心血管代谢性共病管理依从性的社区-患者协同机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Bayesian approaches to identify persons with osteoarthritis in electronic health records and administrative health data in the absence of a perfect reference standard
在缺乏完美参考标准的情况下,贝叶斯方法在电子健康记录和管理健康数据中识别骨关节炎患者
- 批准号:
10665905 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
A novel data-driven approach for personalizing smoking cessation pharmacotherapy
一种新的数据驱动的个性化戒烟药物治疗方法
- 批准号:
10437438 - 财政年份:2022
- 资助金额:
$ 103.15万 - 项目类别:
A novel data-driven approach for personalizing smoking cessation pharmacotherapy
一种新的数据驱动的个性化戒烟药物治疗方法
- 批准号:
10578721 - 财政年份:2022
- 资助金额:
$ 103.15万 - 项目类别:
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
9973785 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
10643861 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别: